Literature DB >> 14617007

Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia.

Marc Tischkowitz1, Najim Ameziane, Quinten Waisfisz, Johan P De Winter, Richard Harris, Toshiyasu Taniguchi, Alan D'Andrea, Shirley V Hodgson, Christopher G Mathew, Hans Joenje.   

Abstract

Fanconi anaemia (FA) is a chromosomal instability disorder associated with a high risk of acute myeloid leukaemia (AML). Previous work has shown that the AML cell line CHRF-288, derived from a sporadic AML-M7 patient, does not express FANCF protein and exhibits a cellular FA phenotype. We show that this phenotype is corrected by a FANCF-expressing plasmid and that the absence of FANCF protein is explained by hypermethylation of the promoter region of the FANCF gene. As FANCF is localized in a hot-spot region for somatic hypermethylation (11p15), FANCF silencing might be an early step in sporadic carcinogenesis, including leukaemogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617007     DOI: 10.1046/j.1365-2141.2003.04640.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  27 in total

1.  Molecular cross-talk among chromosome fragility syndromes.

Authors:  Jordi Surrallés; Stephen P Jackson; Maria Jasin; Michael B Kastan; Stephen C West; Hans Joenje
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

Review 2.  Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.

Authors:  Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

Review 3.  Molecular pathogenesis of Fanconi anemia.

Authors:  Natalie Collins; Gary M Kupfer
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 4.  Fanconi anaemia: from a monogenic disease to sporadic cancer.

Authors:  Antonio Valeri; Sandra Martínez; José A Casado; Juan A Bueren
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

5.  Defects of FA/BRCA pathway in lymphoma cell lines.

Authors:  Hui Xiao; Ke Jian Zhang; Bing Xia
Journal:  Int J Hematol       Date:  2008-11-15       Impact factor: 2.490

Review 6.  Susceptibility pathways in Fanconi's anemia and breast cancer.

Authors:  Alan D D'Andrea
Journal:  N Engl J Med       Date:  2010-05-20       Impact factor: 91.245

7.  Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents.

Authors:  Andreas Palagyi; Kornelia Neveling; Ursula Plinninger; Andreas Ziesch; Bianca-Sabrina Targosz; Gerald U Denk; Stephanie Ochs; Antonia Rizzani; Daniel Meier; Wolfgang E Thasler; Helmut Hanenberg; Enrico N De Toni; Florian Bassermann; Claus Schäfer; Burkhard Göke; Detlev Schindler; Eike Gallmeier
Journal:  Mol Cancer       Date:  2010-05-28       Impact factor: 27.401

Review 8.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

9.  FANCF hypomethylation is associated with colorectal cancer in Han Chinese.

Authors:  Hang Yu; Ranran Pan; Tong Gao; Dongping Wu; Jieer Ying; Shiwei Duan
Journal:  Turk J Gastroenterol       Date:  2020-08       Impact factor: 1.852

Review 10.  The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.

Authors:  Lindsey E Romick-Rosendale; Vivian W Y Lui; Jennifer R Grandis; Susanne I Wells
Journal:  Mutat Res       Date:  2013-01-17       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.